Who invested in Intact Vascular?
Intact Vascular's investors include Quaker Partners, New Enterprise Associates, H.I.G. BioVentures, Vensana Capital and H.I.G. BioHealth Partners.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$105Mraised across 8 rounds since 2012, from 10 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Massdevice and 2 othersSEC filing: $5.0M sold, first sale May 2019
No investor was named in the report.
Reported by MassdeviceSEC filing: $10M sold, first sale Apr 2018
Reported by FinSMEsSEC filing: $39M sold, first sale May 2015
From a historical funding recordSEC filing: $32M sold, first sale May 2015
No investor was named in the report.
From a historical funding recordSEC filing: $3.0M sold, first sale Mar 2015
No investor was named in the report.
From a historical funding recordSEC filing: $4.7M sold, first sale Dec 2013
Reported by intactvascular.comSEC filing: $11M sold, first sale Aug 2012
No investor was named in the report.
Reported by sec.govSEC filing: $1.3M sold, first sale Feb 2012
From the SEC filings it signed: 5 on the team.
On the board, as filediBruce J. RobertsonDennis W. WahrJosh G. MakowerP. Sherrill NeffPeter Justin Klein
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Intact Vascular's investors include Quaker Partners, New Enterprise Associates, H.I.G. BioVentures, Vensana Capital and H.I.G. BioHealth Partners.
Intact Vascular has raised $105M across 8 rounds since 2012.
Intact Vascular's most recent round was an Undisclosed round of $25M in May 2019.
Intact Vascular's largest round on record is $38M (Series B), in May 2015.
Intact Vascular's first round on record, in Sept 2012, was backed by Quaker Partners and H.I.G. BioVentures.
Intact Vascular's latest named round is an Undisclosed round, in May 2019.
Intact Vascular is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.